Oral hyposensitization to nickel induces clinical improvement and a decrease in TH1 and TH2 cytokines in patients with systemic nickel allergy syndrome

/in /da

Autore: Minelli M, Schiavino D, Musca F, Bruno ME, Falagiani P, Mistrello G, Riva G, Braga M, Turi MC, Di Rienzo V, Petrarca C, Schiavone C, Di Gioacchino M

Int J Immunopathol Pharmacol. 2010

Potrebbero interessarti
A clinical trial of oral hyposensitization in systemic allergy to nickel
Nickel allergy is found in a majority of women with chronic fatigue syndrome and muscle pain
Systemic nickel allergy syndrome (SNAS). A review.
Carnosine enhances diabetic wound healing in the db/db mouse model of type 2 diabetes
Survival of Helicobacter pylori in gastric acidic territory. Department of Environmental and Preventive Medicine
Neurological disease in a child with carnosinase deficiency
The European Surveillance System of Contact Allergies (ESSCA): results of patch testing the standard series
Management of contact dermatitis due to nickel allergy: an update.